XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenues:        
Premiums $ 39,585 $ 36,413 $ 78,523 $ 71,224
Products 6,415 6,610 12,544 13,003
Services 3,797 3,269 7,231 6,409
Investment and other income 256 193 478 376
Total revenues 50,053 46,485 98,776 91,012
Operating costs:        
Medical costs 32,549 29,872 64,628 58,302
Operating costs 7,328 6,793 14,350 13,551
Cost of products sold 5,889 6,106 11,565 11,983
Depreciation and amortization 556 511 1,089 1,013
Total operating costs 46,322 43,282 91,632 84,849
Earnings from operations 3,731 3,203 7,144 6,163
Interest expense (301) (271) (584) (530)
Earnings before income taxes 3,430 2,932 6,560 5,633
Provision for income taxes (1,080) (1,172) (2,019) (2,246)
Net earnings 2,350 1,760 4,541 3,387
Earnings attributable to noncontrolling interests (66) (6) (85) (22)
Net earnings attributable to UnitedHealth Group common shareholders $ 2,284 $ 1,754 $ 4,456 $ 3,365
Earnings per share attributable to UnitedHealth Group common shareholders:        
Basic $ 2.37 $ 1.84 $ 4.65 $ 3.53
Diluted $ 2.32 $ 1.81 $ 4.55 $ 3.48
Basic weighted-average number of common shares outstanding 964 951 959 952
Dilutive effect of common share equivalents 21 16 21 15
Diluted weighted-average number of common shares outstanding 985 967 980 967
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 8 1 9 4
Cash dividends declared per common share $ 0.750 $ 0.625 $ 1.375 $ 1.125